Weight Loss Injections vs Weight Loss Pills: Complete Guide

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. All weight loss medications require a prescription and medical supervision. Always consult a qualified healthcare provider before starting any weight loss medication.

The weight loss medication landscape in 2026 includes both injectable and oral options, each with distinct mechanisms, efficacy levels, and practical considerations. Injectable GLP-1 medications have captured headlines with dramatic weight loss results, but several FDA-approved oral medications also play important roles in obesity treatment. This guide compares every major option across both categories so you can understand the full landscape.

The Injectable Options

Semaglutide (Wegovy)

Semaglutide 2.4 mg is the most prescribed injectable weight loss medication. It is a GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves metabolic health. Given as a once-weekly subcutaneous injection.

Average weight loss: 14.9% of body weight (STEP 1 trial, 68 weeks)
Mechanism: GLP-1 receptor agonist
Key side effects: Nausea, vomiting, diarrhea, constipation
Cost: ~$1,300/month brand; significantly less through compounded options

Tirzepatide (Zepbound)

Tirzepatide is a dual GIP/GLP-1 receptor agonist that produces the highest weight loss of any currently approved medication. Also a once-weekly subcutaneous injection.

Average weight loss: 20.9% of body weight (SURMOUNT-1 trial, 72 weeks, 15 mg dose)
Mechanism: Dual GIP and GLP-1 receptor agonist
Key side effects: Similar to semaglutide — nausea, diarrhea, vomiting
Cost: ~$1,060/month brand

Liraglutide (Saxenda)

The first GLP-1 approved for weight loss. A daily injection that has been largely superseded by semaglutide for most patients but remains available and effective.

Average weight loss: 5-8% of body weight
Mechanism: GLP-1 receptor agonist
Key side effects: Nausea, diarrhea, constipation
Cost: ~$1,000-$1,400/month

The Oral Options

Contrave (Naltrexone/Bupropion)

Contrave combines an opioid antagonist with an antidepressant to target the brain's reward and appetite centers. It is taken as a twice-daily oral tablet.

Average weight loss: 5-8% of body weight
Mechanism: Opioid antagonist + norepinephrine-dopamine reuptake inhibitor
Key side effects: Nausea, constipation, headache, insomnia. Carries a boxed warning for suicidal thoughts (bupropion component)
Cost: ~$100-$200/month with savings card
Contraindications: Seizure disorder, eating disorders, opioid use, uncontrolled hypertension

Qsymia (Phentermine/Topiramate ER)

Combines a stimulant appetite suppressant with an anti-seizure medication that also reduces appetite. Taken once daily.

Average weight loss: 7-10% of body weight (at highest dose)
Mechanism: Sympathomimetic amine + anticonvulsant
Key side effects: Tingling in hands/feet, dry mouth, constipation, altered taste, insomnia, cognitive changes
Cost: ~$150-$250/month
Contraindications: Pregnancy (birth defects), glaucoma, hyperthyroidism, MAO inhibitor use

Orlistat (Xenical / OTC: Alli)

Blocks fat absorption in the gut. The only weight loss medication available both by prescription (Xenical, 120 mg) and over the counter (Alli, 60 mg).

Average weight loss: 3-5% of body weight
Mechanism: Lipase inhibitor (blocks fat absorption)
Key side effects: Oily/fatty stools, gas, fecal urgency, fat-soluble vitamin deficiency
Cost: ~$50-$150/month (prescription); ~$30-$60/month (OTC Alli)

Phentermine (Generic)

A stimulant appetite suppressant approved only for short-term use (up to 12 weeks). One of the oldest weight loss medications still prescribed.

Average weight loss: 3-5% of body weight (short-term)
Mechanism: Sympathomimetic amine (stimulant)
Key side effects: Increased heart rate, elevated blood pressure, insomnia, dry mouth, anxiety
Cost: ~$10-$30/month (generic)
Limitation: Approved for short-term use only; potential for dependence

Oral Semaglutide (Rybelsus)

The same active ingredient as Wegovy/Ozempic in an oral tablet form. Currently approved for type 2 diabetes (not weight management), but higher-dose formulations for weight loss are in development.

Average weight loss: 3-5% at 14 mg daily (current max dose)
Mechanism: GLP-1 receptor agonist
Key side effects: Nausea, diarrhea, vomiting (similar to injectable)
Cost: ~$800-$1,000/month
Note: Higher doses (25-50 mg) in trials show weight loss approaching injectable levels

Head-to-Head Efficacy Comparison

Medication	Type	Avg Weight Loss	Frequency
Tirzepatide 15 mg	Injection	20-26%	Weekly
Semaglutide 2.4 mg	Injection	15-17%	Weekly
Qsymia (high dose)	Oral	7-10%	Daily
Liraglutide 3 mg	Injection	5-8%	Daily
Contrave	Oral	5-8%	Twice daily
Orlistat 120 mg	Oral	3-5%	Three times daily

Beyond Weight Loss: Other Benefits

Injectable GLP-1 medications offer additional health benefits that most oral weight loss pills do not:

Cardiovascular protection: Semaglutide showed a 20% reduction in major cardiovascular events in the SELECT trial. No oral weight loss medication has demonstrated this benefit.
Blood sugar control: GLP-1 injectables dramatically improve HbA1c in patients with type 2 diabetes. Contrave and Qsymia have minimal effects on blood sugar.
Kidney protection: Semaglutide demonstrated renal benefits in the FLOW trial.
Anti-inflammatory effects: GLP-1 agonists show evidence of reducing systemic inflammation.

Practical Considerations

Why Some Patients Prefer Injections

Greater weight loss efficacy
Once-weekly dosing (vs daily or multiple times daily)
Additional metabolic benefits
Modern injection pens are nearly painless
No dietary timing restrictions (unlike oral semaglutide)

Why Some Patients Prefer Pills

No needles — important for those with needle phobia
Simpler storage (no refrigeration concerns)
Some oral options are significantly cheaper
Familiar medication format
Easier for travel (no sharps disposal needed)

Making Your Decision

The choice between injections and pills should consider several factors:

Weight loss goals: If you need to lose more than 15% of body weight, injectable GLP-1 medications are likely your best pharmaceutical option.
Budget: If cost is the primary concern, generic phentermine or OTC orlistat are the most affordable. Compounded semaglutide through Trimi offers strong efficacy at reduced cost.
Health conditions: Diabetes, cardiovascular risk, and kidney disease all favor GLP-1 injectables due to their proven benefits in these areas.
Needle comfort: Genuine needle phobia is a valid reason to explore oral options first, though many patients overcome initial anxiety quickly.
Medication interactions: Your current medications may contraindicate certain options (e.g., opioid use rules out Contrave).

The Future: Blurring the Line

The distinction between "injection" and "pill" weight loss medications is becoming less clear. Higher-dose oral semaglutide (25-50 mg) in clinical trials is showing weight loss approaching that of injectable forms. Oral GLP-1 receptor agonists from other manufacturers are also in development. Within a few years, patients may have oral options that rival the efficacy of today's injections.

Until then, injectable GLP-1 medications remain the gold standard for pharmaceutical weight loss. If you are unsure which approach is right for you, schedule a consultation with Trimi to discuss your options with a licensed healthcare provider.

Frequently Asked Questions

Are weight loss injections more effective than pills?

Generally, yes. Injectable GLP-1 medications (semaglutide, tirzepatide) produce the greatest weight loss of any approved medications — typically 15-25% of body weight. Oral options like Contrave, phentermine, and orlistat typically produce 5-10% weight loss. However, individual responses vary, and some patients do well with oral medications.

What are the main weight loss injection options?

The primary injectable weight loss medications are semaglutide (Wegovy) and tirzepatide (Zepbound), both GLP-1 receptor agonists given as weekly subcutaneous injections. Liraglutide (Saxenda) is an older daily GLP-1 injection. All require a prescription and medical supervision.

What weight loss pills are FDA-approved?

FDA-approved oral weight loss medications include Contrave (naltrexone/bupropion), Qsymia (phentermine/topiramate), orlistat (Xenical/Alli), and Rybelsus (oral semaglutide, approved for diabetes but sometimes used off-label for weight loss). Phentermine alone is approved for short-term use. Higher-dose oral semaglutide for weight loss is expected to gain approval.

Do weight loss injections hurt?

Modern GLP-1 injection pens use very thin, short needles (similar to insulin pens). Most patients report minimal discomfort — often just a slight pinch. The injection is subcutaneous (into the fat layer under the skin), not intramuscular, making it far less painful than typical vaccinations. Most patients adapt quickly and do not find the injections to be a significant barrier.

Can I switch from a weight loss pill to an injection?

Yes, switching from oral weight loss medications to injectable GLP-1 medications is common, especially for patients who have not achieved adequate results with pills. Your provider will guide the transition, which may involve stopping the oral medication and starting the injection at the lowest dose with gradual titration.